Effect of SGLT2 inhibitor dapagliflozin on skeletal muscle fatty acid metabolism in patients with type 2 diabetesA. Gemmink,Y. J. M. op den Kamp,M. de Ligt, B. Dautzenberg, R. Esterline,J. Hoeks,V. B. Schrauwen-Hinderling,S. Kersten, B. Havekes,T. R. Koves, D. M. Muio,M. K. C. Hesselink,J. Oscarsson,E. Phielix,P. SchrauwenDIABETOLOGIA(2022)引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要